FacebookLinkedInX

Resources

Resources2021-04-28T14:16:20-04:00

RESOURCES

Browse our Resources

Use the below filters and search to find publications including Amicus Briefs, Testimony and Comments, IPO Law Journal Articles, and the IPO Federal Circuit Summaries™.

TITLE PUBLISHED CATEGORY
IPO Comments to USTR Regarding 2026 Notorious Markets October 07, 2026 Testimony and Comments
CLAIMS RECITING SCIENTIFIC IMPOSSIBILITY WERE DEFINITE BUT NOT ENABLED* * Satius v. Samsung, 25-1446 October 01, 2026 IPO Federal Circuit Summaries
IPO’s 119th Congress Legislative Tracker October 01, 2026 Testimony and Comments
RULE 54(B) PARTIAL JUDGMENT UNAVAILABLE WHERE OTHER CLAIMS OF SAME PATENT REMAIN PENDING* * ParkerVision v. Qualcomm, 26-1033, -1035 September 30, 2026 IPO Federal Circuit Summaries
FEDERAL CIRCUIT VACATES SANCTIONS DENIAL IN LIGHT OF “STRONG INDICATORS” OF PATENT INELIGIBILITY* * Epic Tech, LLC v. Pen-Tech Assocs., Inc., 25-1624 September 30, 2026 IPO Federal Circuit Summaries
FEDERAL CIRCUIT DENIES EN BANC REHEARING OF ANTIBODY METHOD-OF-TREATMENT ENABLEMENT RULING* Teva Pharms. Int'l GmbH v. Eli Lilly & Co., 24-1094 September 30, 2026 IPO Federal Circuit Summaries
Joint IPO, AIPLA, and INTA Letter to Senate Judiciary Subcommittee on IP Regarding Hearing on “Oversight of the USPTO” September 28, 2026 Testimony and Comments
2026 Inventor Rewards & Recognition Survey September 23, 2026 IPO Law Journal
IPO Comments on India Draft Manual of Patent Office Practice & Procedure September 17, 2026 Testimony and Comments
IPO Amicus Brief in RiseandShine v. PepsiCo., 24-1016 September 15, 2026 Amicus Briefs
DISTRICT COURT ERRED IN CONSTRUING CLAIM TERM AS HAVING TWO DIFFERENT MEANINGS* NCS Multistage Inc. v. Nine Energy Serv., Inc., 25-1000 September 14, 2026 IPO Federal Circuit Summaries
*LICENSOR WAS NOT A NECESSARY PARTY TO PATENT INFRINGEMENT SUIT* TexasLDPC Inc. v. Broadcom Inc., 25-1074 September 14, 2026 IPO Federal Circuit Summaries
DISTRICT COURT CORRECTLY FOUND PATENT PREAMBLE LIMITING* * Moskowitz Family LLC v. Globus Med. Inc., 24-1696 September 11, 2026 IPO Federal Circuit Summaries
USPTO OBVIOUSNESS DETERMINATION WAS SUPPORTED BY SUBSTANTIAL EVIDENCE* Netlist, Inc. v. Micron Tech. Inc., 24-1707 September 02, 2026 IPO Federal Circuit Summaries
Joint Association Letter to U.S. Congress Concerning FY27 National Defense Authorization Act September 01, 2026 Testimony and Comments
IPO Comments to CNIPA on the Draft Amendments to the Implementing Rules of the Regulations on the Protection of Integrated Circuit Layout Designs September 01, 2026 Testimony and Comments
Joint Association Letter to U.S. Congress Regarding USPTO Fee-Setting Authority September 01, 2026 Testimony and Comments
SPECIFICATION SUFFICIENTLY IDENTIFIED STRUCTURAL FEATURES OF CRYSTALLINE POLYMORPH GENUS* Exelixis, Inc. v. MSN Labs. Private Ltd., 2025-1236 August 31, 2026 IPO Federal Circuit Summaries
FEDERAL CIRCUIT DID NOT HAVE SUBJECT MATTER JURISDICTION OVER SETTLEMENT DISPUTE* T-Mobile US, Inc. v. KAIFI LLC, 2025-1006 August 28, 2026 IPO Federal Circuit Summaries
DISTRICT COURT MAY CONSIDER § 101 ELIGIBILITY AFTER DETERMINING IMPROPER VENUE* AML IP, LLC v. Bath & Body Works Direct, Inc., 2025-1280 August 28, 2026 IPO Federal Circuit Summaries
IPO Comments to USPTO Regarding Proposed Real-Party-in-Interest Disclosure Requirements for Ex Parte Reexamination Requests August 21, 2026 Testimony and Comments
INVENTOR GROUPS LACKED STANDING TO CHALLENGE PATENT COVER’S “RIGHT TO EXCLUDE” LANGUAGE* * US Inventor, Inc. v. Squires, 24-2378 August 21, 2026 IPO Federal Circuit Summaries
SECTION 287 MARKING REQUIREMENT APPLIES TO SETTLEMENT LICENSES; FAILURE TO PLEAD LICENSEE COMPLIANCE BARS PRE-SUIT DAMAGES* VDPP, LLC v. Volkswagen Group of America, Inc., 24-2226 August 19, 2026 IPO Federal Circuit Summaries
REASONABLY PERTINENT ART NOT LIMITED TO PROBLEM EXPRESSLY IDENTIFIED IN PATENT SPECIFICATION* * The Nielson Co. (US), LLC v. TVision Insights, Inc., 25-1371 August 14, 2026 IPO Federal Circuit Summaries
IPO Comments to China National Copyright Administration on Draft Amendments to the Implementing Regulations of China’s Copyright Law August 12, 2026 Testimony and Comments
FEDERAL CIRCUIT DENIES EN BANC REVIEW OF DESIGN PATENT INFRINGEMENT DECISION* * August 11, 2026 IPO Federal Circuit Summaries
SECTION 102 CONDITIONS PRIOR ART ENTITLEMENT TO PRIORITY ON COMPLIANCE WITH SECTION 112(E)* Dental Monitoring SAS v. Align Tech., Inc., 25-1752 August 10, 2026 IPO Federal Circuit Summaries
DISTRICT COURT IMPROPERLY CONSTRUED CLAIM TERMS IN PRELIMINARY INJUNCTION ORDER* * Socket Solutions, LLC v. Import Gbl., LLC, 25-1121 August 04, 2026 IPO Federal Circuit Summaries
Customer Contracting Toolkit for B2B AI Services July 29, 2026 IPO Law Journal
DISTRICT COURT ERRONEOUSLY RELIED ON EXPERT TESTIMONY IN ANTICIPATION DETERMINATION* * Bd. of Regents of the Univ. of Tex. Sys. v. Boston Sci. Corp., 24-2062, 24-2063 July 27, 2026 IPO Federal Circuit Summaries
Protection of Colour/Color Trade Marks – An International Perspective July 24, 2026 IPO Law Journal
FEDERAL CIRCUIT VACATES COPYRIGHT DAMAGES AWARD FOR ERRONEOUS APPLICATION OF “BOOK OF WISDOM” DOCTRINE* * 4DD Holdings, LLC v. United States, 24-1996 July 16, 2026 IPO Federal Circuit Summaries
DISTRICT COURT ERRED IN GRANTING PRELIMINARY INJUNCTION WHERE THERE WAS SUBSTANTIAL QUESTION OVER CLAIM CONSTRUCTION* * Ridge Corp. v. Kirk NationaLease Co., 25-1254 July 13, 2026 IPO Federal Circuit Summaries
USPTO MAY REVISIT ISSUES NOT NECESSARY TO PRIOR JUDGMENT ON REMAND* Intell. Pixels Ltd. v. Sony Interactive Ent. LLC, 24-2174 July 10, 2026 IPO Federal Circuit Summaries
SPECIFICATION DID NOT GIVE SUFFICIENT GUIDANCE TO ENABLE METHOD OF TREATMENT PATENT* * Wyeth LLC v. AstraZeneca Pharms. LP, 24-2325 July 09, 2026 IPO Federal Circuit Summaries
DYFAN REQUIRES ADDITIONAL ANALYSIS UNDER SECTION 112(F)* * TrackTime, LLC v. Amazon.com Servs. LLC, 24-1102 July 02, 2026 IPO Federal Circuit Summaries
DISTRICT COURT CORRECTLY CONSTRUED CLAIMS TO INCLUDE BOTH FREE BASE AND SALT FORM OF COMPOUNDS* * Otsuka Am. Pharma., Inc. v. Hetero Labs Ltd., 25-2016  July 01, 2026 IPO Federal Circuit Summaries
PATENT LACKED WRITTEN DESCRIPTION DUE TO TYPOGRAPHICAL ERROR IN PROVISIONAL APPLICATION* * Enanta Pharms., Inc. v. Pfizer Inc., 25-1427 June 23, 2026 IPO Federal Circuit Summaries
CLASSIFICATION RESULTS WERE NOT DETERMINATIVE OF DISCOVERABILITY UNDER 35 U.S.C. § 315(E)(2)* * Ironburg Inventions Ltd v. Valve Corp., 24-2088 June 18, 2026 IPO Federal Circuit Summaries
IPO Letter to U.S. Senate Opposing S. 2658, the Medication Affordability and Patent Integrity Act June 16, 2026 Testimony and Comments
Load More
Intellectual Property Owners Association
Powered by  GDPR Cookie Compliance (opens in a new tab)
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.